The Shingles Vaccine Market is expected to register a CAGR of 15.5% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The report is segmented by Product (Shingrix, Zostavax, SkyZoster), By Vaccine Type (Recombinant Vaccine, Live Attenuated Vaccine)
Purpose of the ReportThe report Shingles Vaccine Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Shingles Vaccine Market Segmentation
Product- Shingrix
- Zostavax
- SkyZoster
- Recombinant Vaccine
- Live Attenuated Vaccine
Strategic Insights
Shingles Vaccine Market Growth Drivers- Aging Population: As the global population ages, the incidence of shingles, particularly among individuals over 50, is rising. The aging demographic is more vulnerable to the herpes zoster virus, which causes shingles. This has driven the demand for effective vaccines to prevent the condition, fueling growth in the shingles vaccine market as older adults seek preventive healthcare options to avoid the painful and debilitating symptoms of shingles.
- Increased Awareness and Education: Increased awareness campaigns by healthcare providers and organizations about the risks of shingles and the benefits of vaccination have contributed to higher vaccine uptake. Public health initiatives highlighting the potential complications of shingles, including postherpetic neuralgia (PHN), are encouraging more people to get vaccinated, which has driven market growth by expanding the target population.
- Government Recommendations and Coverage: Several countries have introduced national immunization programs recommending shingles vaccination for older adults, often subsidizing the cost. Government endorsements and insurance coverage for vaccines, particularly for individuals over the age of 50, have positively influenced the market. The availability of financial support and guidance from health authorities makes vaccination more accessible, encouraging individuals to get vaccinated and increasing market demand.
- Shift Toward Recombinant Vaccines: Recombinant vaccines, such as Shingrix, are becoming the preferred choice for shingles vaccination due to their higher efficacy and longer-lasting protection compared to older live-attenuated vaccines. This trend reflects growing demand for more effective vaccines, leading to higher market share for recombinant vaccines. The shift is expected to continue as patients and healthcare professionals prioritize effectiveness in preventing shingles.
- Increased Focus on Preventive Healthcare: A growing global emphasis on preventive healthcare is shaping the shingles vaccine market. As people become more proactive in managing their health, vaccinations for diseases like shingles are seen as a critical preventive measure. This trend is fueled by rising healthcare awareness and an emphasis on reducing the economic burden of disease, propelling demand for shingles vaccines worldwide.
- Adoption of Combination Vaccines: The development of combination vaccines that target multiple diseases, including shingles, is gaining traction. These vaccines simplify the vaccination process by reducing the number of shots required, which appeals to patients and healthcare providers. Combination vaccines also reduce healthcare costs and improve vaccination compliance, contributing to a growing market for multi-disease vaccines that include shingles protection.
- Expanding Market in Developing Regions: While shingles vaccines are well-established in developed countries, there is significant untapped potential in emerging markets. As healthcare infrastructure improves and awareness about shingles increases, these regions present a growing opportunity for vaccine manufacturers to expand their presence and increase vaccine access for older populations at risk of shingles.
- Rising Demand for Vaccination in Younger Populations: Although shingles primarily affects older adults, there is an emerging opportunity to vaccinate younger individuals who are at risk, such as those with weakened immune systems. Expanding vaccine recommendations to include at-risk younger populations, such as those with chronic conditions or immunocompromised states, could increase the market size and offer new growth avenues.
- Innovative Vaccine Development: With ongoing research into more effective vaccines and alternative delivery methods, there are ample opportunities to develop next-generation shingles vaccines. This includes investigating new adjuvants, exploring alternative formulations for easier administration, or developing vaccines that offer longer-lasting protection. Innovative vaccine technologies could significantly enhance market growth by meeting consumer demands for better vaccine options.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Shingles Vaccine Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Shingles Vaccine Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The market growth is driven by an aging population, increased awareness of shingles and its complications, government recommendations for vaccination, and the shift toward more effective recombinant vaccines like Shingrix.
Government recommendations and insurance coverage have significantly boosted vaccine uptake, particularly for older adults. National immunization programs increase accessibility and affordability, which helps drive market growth.
Recombinant vaccines, such as Shingrix, are more effective and have longer-lasting protection, which has led to a higher market share. This shift toward more effective vaccines is expected to continue as consumers and healthcare providers prioritize better outcomes.
Developing regions, particularly in Asia-Pacific, Latin America, and the Middle East, present significant opportunities as healthcare infrastructure improves and awareness of shingles grows. These areas are expected to witness increasing vaccine demand.
As the global focus on preventive healthcare increases, more individuals are seeking vaccines for diseases like shingles. The emphasis on reducing the economic and social burden of diseases drives the demand for shingles vaccines, contributing to market growth.
Combination vaccines, which target multiple diseases in one shot, are gaining popularity as they simplify the vaccination process and reduce healthcare costs. This trend is expected to drive demand for multi-disease vaccines that include shingles protection.
- GlaxoSmithKline
- Merck & Co.
- Sanofi
- Pfizer
- Johnson & Johnson
- Moderna
- Novartis
- AbbVie
- Eli Lilly
- Roche
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For